Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MALTOMA presenting with thrombocytopenia.

Hakan Sakalli1, Zafer Akcali, Fazilet Kayaselcuk

  • 1Division of Medical Oncology, Baskent University, Ankara, Turkey.

American Journal of Clinical Oncology
|June 1, 2005
PubMed
Summary

Immune thrombocytopenia in malignancy is rare with MALT lymphoma without bone marrow infiltration. Treatment with gamma-globulin and chemotherapy successfully resolved thrombocytopenia and achieved remission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Liver Function-based Scores in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation.

In vivo (Athens, Greece)·2026
Same author

Gender Disparities in Response to Neoadjuvant Therapy for Early-Stage Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database.

Breast care (Basel, Switzerland)·2026
Same author

Assessment of Large Language Models in Colorectal Cancer Multidisciplinary Tumor Board Decision-Making: A Retrospective Single-Center Comparison of Guideline-Integrated General-Purpose vs. Domain-Specialized Models.

Current oncology (Toronto, Ont.)·2026
Same author

Time-dependent prognostic impact of distant metastatic sites in small cell lung cancer: a comparative analysis of pre- and post-immunotherapy eras.

Immunotherapy·2026
Same author

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial.

JAMA oncology·2026
Same author

Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial.

NPJ breast cancer·2026

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Immune thrombocytopenia (ITP) is often linked to lymphoproliferative disorders.
  • Thrombocytopenia in Mucosa-Associated Lymphoid Tissue (MALT) lymphoma typically indicates bone marrow infiltration, which is uncommon.
  • Immune-mediated cytopenias in MALT lymphoma patients are rarely documented.

Observation:

  • A patient with stage IIE gastrointestinal MALT lymphoma presented with thrombocytopenia.
  • Bone marrow biopsy showed no evidence of tumor infiltration.
  • Initial treatment with intravenous steroids was ineffective for the thrombocytopenia.

Findings:

  • A single infusion of gamma-globulin led to an increase in platelet count.
  • The patient received 6 cycles of chemotherapy, achieving complete remission.

Related Experiment Videos

  • This case highlights a rare instance of immune-mediated thrombocytopenia in MALT lymphoma.

    • Implications:

    • This case suggests that immune-mediated thrombocytopenia can occur in MALT lymphoma even without bone marrow involvement.
    • Gamma-globulin and chemotherapy represent potential treatment options for such rare presentations.
    • Further research is warranted to understand the mechanisms and optimal management of ITP associated with MALT lymphoma.